Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5150)
All Articles published online
|
Mar 28, 2011 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Manzano-Alonso ML, Castellano-Tortajada G. Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy. World J Gastroenterol 2011; 17(12): 1531-1537 [PMID: 21472116 DOI: 10.3748/wjg.v17.i12.1531] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i12/1531.htm |
| Number | Citing Articles |
| 1 |
Koichi Watashi, Guoxin Liang, Masashi Iwamoto, Hiroyuki Marusawa, Nanako Uchida, Takuji Daito, Kouichi Kitamura, Masamichi Muramatsu, Hirofumi Ohashi, Tomoko Kiyohara, Ryosuke Suzuki, Jisu Li, Shuping Tong, Yasuhito Tanaka, Kazumoto Murata, Hideki Aizaki, Takaji Wakita. Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID). Journal of Biological Chemistry 2013; 288(44): 31715 doi: 10.1074/jbc.M113.501122
|
| 2 |
G. Gentile, R. Foà. Viral infections associated with the clinical use of monoclonal antibodies. Clinical Microbiology and Infection 2011; 17(12): 1769 doi: 10.1111/j.1469-0691.2011.03680.x
|
| 3 |
Gholam Hossein Alishiri, Gholam Ali Ghorbani, Salimzadeh Ahmad. Prevalence of Hepatitis B Infection in Rheumatoid Arthritis Patients. Pakistan Journal of Biological Sciences 2013; 16(15): 747 doi: 10.3923/pjbs.2013.747.750
|
| 4 |
Jie Ruan, Shuo Sun, Xin Cheng, Pengyu Han, Yinge Zhang, Dianxing Sun. Mitomycin, 5-fluorouracil, leflunomide, and mycophenolic acid directly promote hepatitis B virus replication and expression in vitro. Virology Journal 2020; 17(1) doi: 10.1186/s12985-020-01339-5
|
| 5 |
Wu Zhi-Feng, Zhou Le-Yuan, Zhou Xiao-Hui, Gao Ya-Bo, Zhang Jian-Ying, Hu Yong, Zeng Zhao-Chong. TLR4-Dependent Immune Response Promotes Radiation-Induced Liver Disease by Changing the Liver Tissue Interstitial Microenvironment during Liver Cancer Radiotherapy. Radiation Research 2014; 182(6): 674 doi: 10.1667/RR13630.1
|
| 6 |
Anil Seetharam, Robert Perrillo, Robert Gish. Immunosuppression in Patients with Chronic Hepatitis B. Current Hepatology Reports 2014; 13(3): 235 doi: 10.1007/s11901-014-0238-2
|
| 7 |
Chien-Yuan Chen, Feng-Ming Tien, Aristine Cheng, Shang-Yi Huang, Wen-Chien Chou, Ming Yao, Jih-Luh Tang, Hwei-Fang Tien, Wang-Huei Sheng. Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-017-0735-1
|
| 8 |
John A. Thompson, Bryan J. Schneider, Julie Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew Frigault, Brianna Hoffner, Christopher J. Hoimes, Mario Lacouture, Frederick Locke, Matthew Lunning, Nisha A. Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan Oluwole, Sandip P. Patel, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Momen Wahidi, Yinghong Wang, Alyse Johnson-Chilla, Jillian L. Scavone. Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 2019; 17(3): 255 doi: 10.6004/jnccn.2019.0013
|
| 9 |
Mohammad Reza Hedayati-Moghaddam, Hossein Soltanian, Masoud Behzadifar. Occult Hepatitis B Virus Infection Prevalence Among Different Populations of Iran: A Systematic Review and Meta-Analysis. Hepatitis Monthly 2020; 20(6) doi: 10.5812/hepatmon.101722
|
| 10 |
Ilkay Bozkurt, Hatun Ozturk Cerik, Seher Kir, Muge Ustaoglu, Mehmet Turgut, Saban Esen. Evaluation of Hepatitis B screening and reactivation in patients receiving rituximab containing chemotherapy: A single‐centre study. International Journal of Clinical Practice 2021; 75(10) doi: 10.1111/ijcp.14685
|
| 11 |
Mehdi Zobeiri. Occult Hepatitis B: Clinical Viewpoint and Management. Hepatitis Research and Treatment 2013; 2013: 1 doi: 10.1155/2013/259148
|
| 12 |
Rosa Maria Morillas, David López Sisamón. Reactivación de la hepatitis B asociada a agentes inmunodepresores y a quimioterapia. Historia natural, factores de riesgo y recomendaciones para prevenirla. Medicina Clínica 2019; 152(3): 107 doi: 10.1016/j.medcli.2018.08.018
|
| 13 |
Paul Martin, Daryl T.-Y. Lau, Mindie H. Nguyen, Harry L.A. Janssen, Douglas T. Dieterich, Marion G. Peters, Ira M. Jacobson. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update. Clinical Gastroenterology and Hepatology 2015; 13(12): 2071 doi: 10.1016/j.cgh.2015.07.007
|
| 14 |
Rosa Maria Morillas, David López Sisamón. Reactivation of hepatitis B associated with immunosuppressants and chemotherapy. Natural history, risk factors and recommendations for prevention. Medicina Clínica (English Edition) 2019; 152(3): 107 doi: 10.1016/j.medcle.2018.12.006
|
| 15 |
Sarosh Ahmed Khan, Rida Zahid, Muhammad Amir. Upadacitinib-Induced Hepatitis B Reactivation Leading to Liver Transplant. ACG Case Reports Journal 2024; 11(4): e01327 doi: 10.14309/crj.0000000000001327
|
| 16 |
Amanda Abramson, Alan Menter, Robert Perrillo. Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for management. Journal of the American Academy of Dermatology 2012; 67(6): 1349 doi: 10.1016/j.jaad.2012.04.036
|
| 17 |
Shintaro Akiyama, Thomas G Cotter, Atsushi Sakuraba. Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics. World Journal of Gastroenterology 2021; 27(19): 2312-2324 doi: 10.3748/wjg.v27.i19.2312
|
| 18 |
Qiao Zhou, Qi Zhang, Kaiwen Wang, Ting Huang, Shaoping Deng, Yi Wang, Chunming Cheng. Anti-rheumatic drug-induced hepatitis B virus reactivation and preventive strategies for hepatocellular carcinoma. Pharmacological Research 2022; 178: 106181 doi: 10.1016/j.phrs.2022.106181
|
| 19 |
Jasmine Samal, Manish Kandpal, Perumal Vivekanandan. Molecular Mechanisms Underlying Occult Hepatitis B Virus Infection. Clinical Microbiology Reviews 2012; 25(1): 142 doi: 10.1128/CMR.00018-11
|
| 20 |
April W. Armstrong, Lakshi Aldredge, Paul S. Yamauchi. Managing Patients With Psoriasis in the Busy Clinic. Journal of Cutaneous Medicine and Surgery 2016; 20(3): 196 doi: 10.1177/1203475415623508
|
| 21 |
Yujie Qin, Wenxiu Zhou, Xingnian Zhou, Hong Li. Case report: Recombinant human type II tumour necrosis factor receptor-antibody fusion protein induced occult hepatitis B virus reactivation leading to liver failure. Journal of International Medical Research 2024; 52(5) doi: 10.1177/03000605241252580
|
| 22 |
LEI XU, ZENG TU, GE XU, YUWEI WANG, WANLONG PAN, XINGXING ZHAN, QIANG LUO, YUAN HUANG, JUAN CHEN, AILONG HUANG. Epirubicin directly promotes hepatitis B virus (HBV) replication in stable HBV-expressing cell lines: A novel mechanism of HBV reactivation following anticancer chemotherapy. Molecular Medicine Reports 2014; 9(4): 1345 doi: 10.3892/mmr.2014.1973
|
| 23 |
Yoichi Iwafuchi, Yuko Oyama, Takashi Morita, Akira Kamimura, Shigeru Miyazaki, Ichiei Narita. De novo acute hepatitis B in myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody-related microscopic polyangiitis treated with corticosteroids. CEN Case Reports 2013; 2(1): 28 doi: 10.1007/s13730-012-0033-2
|
| 24 |
Alissa Visram, Jordan J. Feld. Defining and grading HBV reactivation. Clinical Liver Disease 2015; 5(2): 35 doi: 10.1002/cld.426
|
| 25 |
M.L. Manzano Alonso, I. Fernández Vázquez. Reactivación de la hepatitis B: prevención y tratamiento. Medicine - Programa de Formación Médica Continuada Acreditado 2012; 11(9): 568 doi: 10.1016/S0304-5412(12)70349-9
|
| 26 |
Chien-Yuan Chen, Sheng-Yi Huang, Aristine Cheng, Wen-Chien Chou, Ming Yao, Jih-Luh Tang, Woei Tsay, Wang-Huei Sheng, Hwei-Fang Tien, Chien-Wei Su. High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia. PLOS ONE 2015; 10(5): e0126037 doi: 10.1371/journal.pone.0126037
|
| 27 |
Hyo Jin Kim, Dong Hyun Sinn, Nam Jun Kim, Jung Hee Kim, Eun Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo. Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors. Digestive Diseases and Sciences 2015; 60(12): 3794 doi: 10.1007/s10620-015-3812-8
|
| 28 |
W.-J. Mayet. Differenzialdiagnose der Transaminasenerhöhung bei rheumatischen Erkrankungen. Zeitschrift für Rheumatologie 2015; 74(2): 137 doi: 10.1007/s00393-014-1501-1
|
| 29 |
Jing Fang, Wenge Li, Min Tan, Xiangxin Peng, Zhao Tan, Wenbo Wang. Effect of different hepatitis B infection status on the prognosis of active lupus nephritis treated with immunosuppression: a retrospective analysis of 177 patients. International Journal of Rheumatic Diseases 2018; 21(5): 1060 doi: 10.1111/1756-185X.13313
|
| 30 |
Antonio Guardiola Arévalo, Rafael Gómez Rodríguez, Marta Romero Gutiérrez, Ana Zaida Gómez Moreno, Almudena García Vela, Raquel Sánchez Simón, Cesar Gómez Hernando, Eva María Andrés Esteban. Características y evolución de la infección crónica por virus de la hepatitis B antígeno e negativo. Gastroenterología y Hepatología 2017; 40(2): 59 doi: 10.1016/j.gastrohep.2016.11.002
|
| 31 |
Aneeda Khraibet Abed, Zaytoon A Alkhafaji, Ali Jaber Abood. Serological detection of hepatitis B virus e antigen and TNF-α in a dialysis patient. Medical Journal of Babylon 2023; 20(4): 771 doi: 10.4103/MJBL.MJBL_342_23
|
| 32 |
Sema Sezgin Göksu, Şerife Bilal, Hasan Şenol Coşkun. Hepatitis B reactivation related to everolimus. World Journal of Hepatology 2013; 5(1): 43-45 doi: 10.4254/wjh.v5.i1.43
|
| 33 |
Antonio Guardiola Arévalo, Rafael Gómez Rodríguez, Marta Romero Gutiérrez, Ana Zaida Gómez Moreno, Almudena García Vela, Raquel Sánchez Simón, Cesar Gómez Hernando, Eva María Andrés Esteban. Characteristics and course of chronic hepatitis B e antigen-negative infection. Gastroenterología y Hepatología (English Edition) 2017; 40(2): 59 doi: 10.1016/j.gastre.2016.11.009
|
| 34 |
Zhi-Feng Wu, Xiao-Hui Zhou, Yun-Wen Hu, Le-Yuan Zhou, Ya-Bo Gao, Xiu-Hua Peng, Xiao-Hua Yang, Jian-Ying Zhang, Yong Hu, Zhao-Chong Zeng. TLR4-dependant immune response, but not hepatitis B virus reactivation, is important in radiation-induced liver disease of liver cancer radiotherapy. Cancer Immunology, Immunotherapy 2014; 63(3): 235 doi: 10.1007/s00262-013-1504-9
|
| 35 |
Meng-Tzu Weng, Chien-Chih Tung, Yuan-Ting Chang, Yew-Loong Leong, Yu-Ting Wang, Jau-Min Wong, Shu-Chen Wei. Trends of Medication Usage and Associated Outcomes for Taiwanese Patients with Inflammatory Bowel Disease from 2001 to 2015. Journal of Clinical Medicine 2018; 7(11): 394 doi: 10.3390/jcm7110394
|
| 36 |
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Elena Penza, Ottavia Magnani, Francesco Puppo. Infection risk associated with anti-TNF-α agents: a review. Expert Opinion on Drug Safety 2015; 14(4): 571 doi: 10.1517/14740338.2015.1009036
|
| 37 |
Alison G. Freifeld, Daniel R. Kaul. Abeloff's Clinical Oncology. 2014; : 562 doi: 10.1016/B978-1-4557-2865-7.00036-9
|
| 38 |
David J. Weber, Erica S. Shenoy. Plotkin's Vaccines. 2023; : 1469 doi: 10.1016/B978-0-323-79058-1.00072-4
|
| 39 |
Jeong Won Jang. Management of Patients with Hepatitis B Virus Infection Who Receive Immunosuppressive Treatment or Chemotherapy. Korean Journal of Medicine 2012; 82(2): 149 doi: 10.3904/kjm.2012.82.2.149
|
| 40 |
K. Awasthi, Asmita Das, T. Prasad. Molecular Markers in Mycology. Fungal Biology 2017; : 335 doi: 10.1007/978-3-319-34106-4_16
|
| 41 |
Hiroki Kaneko, Yoshinori Ozono, Hisayoshi Iwakiri, Hiroshi Hatada, Naomi Uchiyama, Yuri Komaki, Kenichi Nakamura, Satoru Hasuike, Kenji Nagata, Hiroshi Kawakami. Reactivation of hepatitis C virus caused by steroid monotherapy for sudden deafness. Clinical Journal of Gastroenterology 2024; 17(3): 505 doi: 10.1007/s12328-024-01944-9
|
| 42 |
J. Koskinas, M. Tampaki, P.P. Doumba, E. Rallis. Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient. British Journal of Dermatology 2013; 168(3): 679 doi: 10.1111/bjd.12120
|
| 43 |
Robert Hirten, Keith Sultan, Ashby Thomas, David E Bernstein. Hepatic manifestations of non-steroidal inflammatory bowel disease therapy. World Journal of Hepatology 2015; 7(27): 2716-2728 doi: 10.4254/wjh.v7.i27.2716
|
| 44 |
Ahmet Murt, Tugrul Elverdi, Ahmet Emre Eskazan, Ayse Salihoglu, Muhlis Cem Ar, Seniz Ongoren, Zafer Baslar, Teoman Soysal. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology 2020; 99(11): 2671 doi: 10.1007/s00277-020-04206-z
|
| 45 |
Qingbao Ding, Keyu Wang, Yupeng Li, Peng Peng, Dongyuan Zhang, Donglei Chang, Wentao Wang, Lei Ren, Fang Tang, Ziqiang Li. Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation. American Journal of Clinical Oncology 2023; 46(7): 284 doi: 10.1097/COC.0000000000001004
|
| 46 |
M. Mouler Rechtman, E. O. Burdelova, I. Bar‐Yishay, M. Ben‐Yehoyada, S. Fishman, Z. Halpern, A. Shlomai. The metabolic regulator PGC‐1α links anti‐cancer cytotoxic chemotherapy to reactivation of hepatitis B virus. Journal of Viral Hepatitis 2013; 20(1): 34 doi: 10.1111/j.1365-2893.2012.01622.x
|
| 47 |
Alison G. Freifeld, Daniel R. Kaul. Abeloff's Clinical Oncology. 2020; : 544 doi: 10.1016/B978-0-323-47674-4.00034-7
|
| 48 |
Nuria Dominguez, Maria Luisa Manzano, Raquel Muñoz, Ana Martin, Inmaculada Fernandez, Gregorio Castellano. Late reactivation of occult hepatitis B virus infection in a patient with chronic lymphocytic leukemia after rituximab and fludarabine-based regimen. Leukemia & Lymphoma 2015; 56(4): 1160 doi: 10.3109/10428194.2014.947978
|
| 49 |
Shinta Mizuno, Yoshiyuki Yamagishi, Hirotoshi Ebinuma, Nobuhiro Nakamoto, Mai Katahira, Aya Sasaki, Michiie Sakamoto, Hidekazu Suzuki, Takanori Kanai, Toshifumi Hibi. Progressive liver failure induced by everolimus for renal cell carcinoma in a 58-year-old male hepatitis B virus carrier. Clinical Journal of Gastroenterology 2013; 6(2): 188 doi: 10.1007/s12328-013-0371-4
|
| 50 |
Eleonora Teplinsky, Derrick Cheung, Ilan Weisberg, Ramon E. A. Jacobs, Martin Wolff, James Park, Kent Friedman, Franco Muggia, Komal Jhaveri. Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature. Breast Cancer Research and Treatment 2013; 141(2): 167 doi: 10.1007/s10549-013-2681-0
|
| 51 |
Yutaka Tsutsumi, Reiki Ogasawara, Naohiro Miyashita, Junji Tanaka, Masahiro Asaka, Masahiro Imamura. HBV reactivation in malignant lymphoma patients treated with rituximab and bendamustine. International Journal of Hematology 2012; 95(5): 588 doi: 10.1007/s12185-012-1050-9
|
| 52 |
Fernando Bessone, Melisa Dirchwolf. Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations. World Journal of Hepatology 2016; 8(8): 385-394 doi: 10.4254/wjh.v8.i8.385
|
| 53 |
Klaas Poelstra, Jai Prakash, Leonie Beljaars. Drug targeting to the diseased liver. Journal of Controlled Release 2012; 161(2): 188 doi: 10.1016/j.jconrel.2012.02.011
|
| 54 |
Lei Xu, Zeng Tu, Ge Xu, Jie-Li Hu, Xue-Fei Cai, Xing-Xing Zhan, Yu-Wei Wang, Yuan Huang, Juan Chen, Ai-Long Huang. S-phase arrest after vincristine treatment may promote hepatitis B virus replication. World Journal of Gastroenterology 2015; 21(5): 1498-1509 doi: 10.3748/wjg.v21.i5.1498
|
| 55 |
A. El Mekkaoui, Z. Benbrahim, O. El Mesbahi, A. Ibrahimi, N. Aqodad. Traitement préemptif de la réactivation de l’hépatite virale B des patients sous chimiothérapie anticancéreuse. Journal Africain du Cancer / African Journal of Cancer 2014; 6(1): 47 doi: 10.1007/s12558-013-0299-4
|
| 56 |
Giuseppe Murdaca, Simone Negrini, Marco Pellecchio, Monica Greco, Chiara Schiavi, Francesca Giusti, Francesco Puppo. Update upon the infection risk in patients receiving TNF alpha inhibitors. Expert Opinion on Drug Safety 2019; 18(3): 219 doi: 10.1080/14740338.2019.1577817
|
| 57 |
Jing Fang, Wenge Li, Xiangxin Peng, Zhao Tan, Min Tan, Cong Zhang, Wenbo Wang, Zhihong Xu, Gumin Zhou. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis. International Urology and Nephrology 2017; 49(3): 475 doi: 10.1007/s11255-016-1487-5
|
| 58 |
Dan Yang, Longchao Liu, Danming Zhu, Hua Peng, Lishan Su, Yang-Xin Fu, Liguo Zhang. A mouse model for HBV immunotolerance and immunotherapy. Cellular & Molecular Immunology 2014; 11(1): 71 doi: 10.1038/cmi.2013.43
|
| 59 |
Yi-Chang Liu, Chi-Mu Hsu, Samuel Yien Hsiao, Hui-Hua Hsiao. Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Personalized Medicine 2021; 11(11): 1108 doi: 10.3390/jpm11111108
|
| 60 |
Maarten A. A. van de Klundert, Formijn J. van Hemert, Hans L. Zaaijer, Neeltje A. Kootstra, Sang-Hoon Ahn. The Hepatitis B Virus X Protein Inhibits Thymine DNA Glycosylase Initiated Base Excision Repair. PLoS ONE 2012; 7(11): e48940 doi: 10.1371/journal.pone.0048940
|
| 61 |
Kosuke Sato, Jun Inoue, Eiji Kakazu, Masashi Ninomiya, Tomoaki Iwata, Akitoshi Sano, Mio Tsuruoka, Atsushi Masamune. Reactivation of hepatitis C virus with severe hepatitis flare during steroid administration for interstitial pneumonia. Clinical Journal of Gastroenterology 2021; 14(4): 1221 doi: 10.1007/s12328-021-01432-4
|
| 62 |
David J. Weber, William A. Rutala. Plotkin's Vaccines. 2018; : 1402 doi: 10.1016/B978-0-323-35761-6.00072-9
|
| 63 |
Apostolos Koffas, Grace E Dolman, Patrick TF Kennedy. Hepatitis B virus reactivation in patients treated with immunosuppressive drugs: a practical guide for clinicians. Clinical Medicine 2018; 18(3): 212 doi: 10.7861/clinmedicine.18-3-212
|